Geospiza, NuGEN partner to develop seamless next-generation sequencing workflow

Geospiza, Inc., the market leading developer of genetic analysis software, and NuGEN Technologies, Inc., the leader in sample preparation solutions for clinical samples, today announced a co-marketing agreement to develop a seamless next-generation sequencing workflow to accelerate discoveries for large disease research studies.

“Our innovative sample preparation capabilities complement nicely with Geospiza's platform”

"There is a need to speed research and discovery using methodologies such as Next Generation Sequencing, especially for disease studies involving a large number of samples," said Brandon Young, Genomics Core Manager at The Scripps Research Institute. "We're looking forward to testing the integrated workflow."

"Geospiza's lab and analysis software tools are focused on making research easier, faster and more cost effective," said Rob Arnold, Geospiza's President. "Combining our GeneSifter^® preconfigured lab and analysis cloud software with NuGEN's Ovation^®and Encore™ reagents enables researchers to follow and document a step-by-step best practice for sample preparation combined with fully integrated data analysis and other sample information in one system."

"Our innovative sample preparation capabilities complement nicely with Geospiza's platform," said Elizabeth Hutt, CEO of NuGEN Technologies. "Together NuGEN and Geospiza are developing a scalable integrated workflow that accelerates throughput and removes sample preparation and analysis bottlenecks in next-gen sequencing."